Abstract: This report describes the diagnosis and successful management of a yearling filly with Coombs-positive anemia, thrombocytopenia, and fungal pneumonia. Diagnostic procedures, including thoracic ultrasonography and radiography, respiratory pathogen PCR testing, and evaluation of tracheal wash and bronchoalveolar lavage samples established multi-pathogen lower respiratory tract infection including a fungal agent. Orally administered voriconazole was a key component of treatment in this case to successfully eliminate fungal infection, alongside therapies for managing hematologic disease. This case demonstrated the importance of comprehensive diagnostic evaluation and reliance on current literature to successfully resolve a complicated medical situation that was expected to have a poor prognosis. Key clinical message: The pharmacokinetics of orally administered voriconazole have been established in horses. This drug can be economic and effective for the treatment of some fungal respiratory infections of horses. Infection multi-pathogène des voies respiratoires inférieures, incluant un agent fongique, chez une pouliche mustang d’un anCe rapport décrit le diagnostic et la prise en charge réussie d’une pouliche d’un an présentant une anémie positive au test de Coombs, une thrombocytopénie et une pneumonie fongique. Les examens diagnostiques, incluant une échographie et une radiographie thoraciques, un test PCR de détection des agents pathogènes respiratoires et l’analyse des échantillons de lavage trachéal et broncho-alvéolaire, ont permis d’établir une infection multi-pathogène des voies respiratoires inférieures, incluant un agent fongique. Le voriconazole administré par voie orale a joué un rôle clé dans le traitement de ce cas pour éliminer l’infection fongique, parallèlement aux traitements de prise en charge des maladies hématologiques. Ce cas a démontré l’importance d’une évaluation diagnostique complète et de la fiabilité des données de la littérature pour résoudre efficacement une situation médicale complexe dont le pronostic était sombre.Message clinique clé :La pharmacocinétique du voriconazole administré par voie orale a été établie chez les chevaux. Ce médicament peut être économique et efficace pour le traitement de certaines infections respiratoires fongiques chez les chevaux.(Traduit par D Serge Messier).
Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This research article reports the diagnosis and successful treatment of a yearling mustang filly suffering from a complex lower respiratory tract infection involving multiple pathogens, including a fungal agent.
Key to treatment was the use of orally administered voriconazole to address the fungal infection alongside therapies for blood-related abnormalities, demonstrating the importance of comprehensive diagnostics and current medical knowledge.
Detailed Explanation
Case Description and Clinical Findings
The subject of the report is a yearling mustang filly presenting with multiple health issues:
Coombs-positive anemia – an immune-mediated destruction of red blood cells.
Thrombocytopenia – a reduced platelet count affecting blood clotting.
Fungal pneumonia – infection of the lungs caused by fungal organisms.
The combination of hematologic abnormalities and respiratory infection indicated a complex medical case requiring thorough investigation.
Diagnostic Investigations
Various diagnostic tools were utilized to identify the cause and severity of the illness:
Thoracic ultrasonography and radiography provided imaging insights into lung abnormalities consistent with pneumonia.
Respiratory pathogen PCR testing allowed sensitive detection of multiple infectious agents involved in the lower respiratory tract infection.
Analysis of tracheal wash and bronchoalveolar lavage samples helped isolate the specific fungal agents involved.
The investigation confirmed a multi-pathogen infection, implicating both bacterial and fungal pathogens in the respiratory disease.
Treatment Approach
Treatment targeted the complicated nature of the disease encompassing fungal infection and hematologic issues:
Oral voriconazole administration played a central role in eliminating the fungal pneumonia; this antifungal drug’s pharmacokinetics are well-established for horses, making it effective and economically viable.
Concurrent therapies addressed the blood abnormalities to stabilize the filly’s hematologic health.
The integrated treatment plan successfully resolved the infection and associated clinical conditions, despite an initially poor prognosis.
Significance and Clinical Message
This case underscores the importance of:
Comprehensive diagnostic approaches combining imaging, molecular testing, and cytological analysis to identify multifactorial infections.
Utilizing current pharmacological knowledge in veterinary medicine to optimize treatment outcomes, exemplified by the successful use of voriconazole in horses.
Recognizing that fungal infections can be effectively treated with oral antifungal drugs, expanding therapeutic options for equine respiratory diseases.
The findings suggest that even complicated respiratory infections with poor expected outcomes may be successfully managed with informed and targeted interventions.
Summary
The report details a complex case of multi-pathogen respiratory infection including fungal pneumonia in a young mustang filly, accompanied by anemia and thrombocytopenia.
Advanced diagnostics confirmed the condition, guiding treatment with oral voriconazole and hematologic therapies.
This case illustrates the value of comprehensive evaluation and up-to-date treatment strategies in resolving complicated equine respiratory infections.
Cite This Article
APA
Calero IM, McKenzie EC, Johns JL.
(2025).
Multi-pathogen lower respiratory tract infection including a fungal agent in a yearling mustang filly.
Can Vet J, 66(12), 1279-1285.
Herbrecht R, Denning DW, Patterson TF. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.. N Engl J Med 2002;347:408–415.
Jeong Y, Kim Y-H, Ahn J-O, Chung J-Y. Simultaneous hypersensitivity reactions to trimethoprim-sulfamethoxazole and amoxicillin-clavulanate in a dog. J Vet Sci 2023;24:e77.
Cudmore L, Jalim S, Williamson MM, McKinnon AO. Pancytopenia in two horses following administration of potentiated sulfonamide antimicrobials. Equine Vet Educ 2015;27:519–523.